久久婷婷国产综合精品,久久久久久久性潮,换脸国产av一区二区三区,韩国精品一区二区三区无码视频 ,久久久久成人精品无码

  • Agios Submits sNDA for TIBSOVO for IDH1-Mutant Cholangiocarcinoma americanpharmaceuticalreview
    March 04, 2021
    Agios Pharmaceuticals has submitted a Supplemental New Drug Application (sNDA) to the U.S. Food and Drug Administration (FDA) for TIBSOVO? (ivosidenib tablets) as a potential treatment for patients with previously treated isocitrate dehydrogenase 1 ...

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194
+86 15021993094

PharmaSources Customer Service